In our previous study, we demonstrated that hyaluronan induces odontoblastic 39 differentiation of dental pulp stem cells via interactions with CD44. However, it remains 40 unclear whether CD44 expression by dental pulp stem cells is required for odontoblastic 41 differentiation. Therefore, we searched for a compound that induces odontoblastic 42 differentiation of dental pulp stem cells, regardless of the chemical structure and function 43 of hyaluronan, and examined whether CD44 is involved in the induction of odontoblastic 44 differentiation by the compound. Because vitamin K analogues can promote bone 45 formation and tissue calcification, we focused on derivatives of naphthoquinone, the 46 skeleton of vitamin K; we verified whether those compounds could induce odontoblastic 47 differentiation of dental pulp stem cells. We found that dentin sialophosphoprotein, a 48 marker of odontoblasts, was expressed in dental pulp stem cells after treatment with 49 shikonin. The shikonin-induced expression of dentin sialophosphoprotein was inhibited 50 by PI3K, AKT, and mTOR inhibitors. In addition, in dental pulp stem cells transfected 51 with siRNA against CD44, the shikonin-induced expression of dentin 52 sialophosphoprotein was inhibited. Thus, shikonin can stimulate dental pulp stem cells to 53 undergo odontoblastic differentiation through a mechanism involving the AKT-mTOR 54 signaling pathway and CD44. Hyaluronan stimulated dental pulp stem cells to undergo 55 CD44-mediated odontoblastic differentiation in our previous study; the present study 56 indicated that CD44 is necessary for dental pulp stem cells to undergo odontoblastic 57 differentiation. Although expression of CD44 is important for inducing odontoblastic 58 differentiation of dental pulp stem cells, the relationship between the AKT-mTOR 59 signaling pathway and CD44 expression, in the context of shikonin stimulation, has not 60 yet been elucidated. This study suggested that shikonin may be useful for inducing 61 odontoblastic differentiation of dental pulp stem cells, and that it may have clinical 62 applications, including protection of dental pulp. 63 64 67 CD44 [1]
Introduction 65
In our previous study, we demonstrated that hyaluronan, a large molecule, induces 66 odontoblastic differentiation of dental pulp stem cells (DPSCs) via interactions with and participate in calcification. 90 Although the intracellular signaling of DPSCs stimulated with hyaluronan involves 91 activation of various signals (e.g., MAPK and AKT) in a CD44-mediated manner, the 92 causal relationship between odontoblastic differentiation of DPSCs and these activating 93 signals is not clear. To the best of our knowledge, there have been few reports of inducers 94 or factors (e.g., hyaluronan) that efficiently induce odontoblastic differentiation of DPSCs. 95 Furthermore, it remains unclear whether CD44 is required to induce odontoblastic 96 differentiation of DPSCs. Notably, menatetrenone (a vitamin K 2 analogue) is used 97 clinically as an osteoporosis treatment and hemostatic agent; it is known to be involved 98 in bone formation, tissue calcification, and blood coagulation [17, 18] . However, the 99 clinical significance of menatetrenone in the dental field has not been fully investigated. 100 In this study, we focused on vitamin K analogues containing naphthoquinone derivatives, 101 to determine whether these analogues can induce odontoblastic differentiation of DPSCs. 102 Then, we explored small molecules involved in inducing odontoblastic differentiation of First, we examined whether naphthoquinone derivatives, which constitute the skeleton 167 of vitamin K, could induce odontoblastic differentiation of DPSCs. We found that, 168 among the vitamin K analogues we examined, shikonin prominently induced expression 169 of DSPP, a marker of odontoblastic differentiation (Fig 1) . This result suggested that 170 shikonin could induce differentiation of DPSCs into odontoblasts. Next, we examined the 50% inhibitory concentrations of shikonin and its enantiomer, 179 alkannin, against DPSCs (Fig 2A) . The 50% inhibitory concentrations did not 180 significantly differ between shikonin (4.48 ± 0.51 μM) and alkannin (5.08 ± 1.21 μM) (Table 1) . Furthermore, DSPP was expressed by DPSCs stimulated with shikonin 182 concentrations greater than 0.1 μM ( Fig 2B) . Conversely, stimulation with alkannin did 183 not induce expression of DSPP by DPSCs ( Fig 2C) . These results suggested that shikonin 184 could induce differentiation of DPSCs to odontoblasts in an enantioselective manner. shikonin treatment ( Fig 3A) ; mTOR phosphorylation was also observed between 30 and 194 90 min after shikonin treatment ( Fig 3B) . Based on these results, we hypothesized that 195 AKT and mTOR play important roles in the mechanism by which shikonin induces 196 odontoblastic differentiation of DPSCs. Thus, we investigated whether DSPP expression 197 was inhibited upon administration of inhibitors for these proteins. When the 198 phosphorylation of AKT was suppressed by treatment with the PI3K inhibitor, Ly294002, 199 the expression of DSPP was suppressed (Fig 3C, D) . In addition, when AKT was 200 inhibited with the pan-AKT kinase inhibitor, GSK690693, the expression of DSPP was 201 suppressed (Fig 3E, F) . Furthermore, when phosphorylation of mTOR was inhibited by 202 the mTOR inhibitor, rapamycin, the expression of DSPP was suppressed (Fig 3G, H) . DPSCs, despite shikonin treatment (Fig 4A) . To investigate the relationships between 224 shikonin and CD44 with respect to the odontoblastic differentiation of DPSCs via AKT-225 mTOR signaling, we examined changes in AKT-mTOR signaling after shikonin 226 treatment in DPSCs that had been treated with CD44 siRNA. When CD44 was inhibited, 227 both AKT and mTOR signaling pathways were induced by shikonin treatment (Fig 4B) . Vitamin K is a lipophilic vitamin involved in post-translational protein modifications 247 associated with various blood coagulation factors [19] . Furthermore, it is involved in the 248 production of vitamin K-dependent bone matrix proteins, such as osteocalcin [20] . 249 Menatetrenone, a vitamin K analogue, has been used as an osteoporosis therapeutic agent 250 or a hemostatic agent [21] . Therefore, we focused on vitamin K analogues in this study, 251 and found that shikonin could induce odontoblastic differentiation. Shikonin is known as DPSCs. Furthermore, CD44 was required for shikonin-induced odontoblastic 280 differentiation.
281
Our study showed that shikonin could induce odontoblastic differentiation of DPSCs.
282
The AKT-mTOR signaling pathway was the main intracellular mechanism involved; 283 moreover, CD44 was important for the induction of odontoblastic differentiation.
284
However, it remains unclear how the AKT-mTOR signaling pathway and CD44 are 285 specifically related to the shikonin-induced odontoblastic differentiation of DPSCs. In 286 addition, it remains unknown whether this effect of shikonin is present in vivo.
287
Our previous study indicated that the hyaluronan-induced odontoblastic differentiation 288 of DPSCs was mediated by CD44. In the present study, the expression of CD44 was found 289 to be important for inducing the odontoblastic differentiation of DPSCs, regardless of the 290 presence or absence of treatment with hyaluronan. To the best of our knowledge, this 291 study is the first report that shikonin can induce odontoblastic differentiation of DPSCs 292 via CD44 and the AKT-mTOR signaling pathway. Because CD44-expressing cells are 293 abundant in incomplete apical areas, pulp horn, and pulp chamber roof [15, 16] , shikonin 294 may be a useful inducer of odontoblastic differentiation, and may have potential clinical 295 use in the protection of pulp. 
